<VariationArchive RecordType="classified" VariationID="832003" VariationName="NC_000002.12:g.(?_32063826)_(32098897_?)del" VariationType="Deletion" Accession="VCV000832003" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819160" VariationID="832003">
      <GeneList>
        <Gene Symbol="SPAST" FullName="spastin" GeneID="6683" HGNC_ID="HGNC:11233" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="32063556" stop="32157637" display_start="32063556" display_stop="32157637" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="32288679" stop="32382705" display_start="32288679" display_stop="32382705" Strand="+" />
          </Location>
          <OMIM>604277</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SPAST">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SPAST">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.12:g.(?_32063826)_(32098897_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="32288895" innerStop="32323966" display_start="32288895" display_stop="32323966" variantLength="35072" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_32288895)_(32323966_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_32288895)_(32323966_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.12:g.(?_32063826)_(32098897_?)del AND Hereditary spastic paraplegia 4" Accession="RCV001032525" Version="1">
        <ClassifiedConditionList TraitSetID="6399">
          <ClassifiedCondition DB="MedGen" ID="C1866855">Hereditary spastic paraplegia 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-10-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-10-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17035675</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20562464</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24690193</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6399" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4415" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 4, autosomal dominant</ElementValue>
                <XRef ID="Spastic+paraplegia+4/6695" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 4</ElementValue>
                <XRef ID="MONDO:0008438" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraplegia autosomal dominant 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FSP2</ElementValue>
                <XRef Type="MIM" ID="182601" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPG4</ElementValue>
                <XRef Type="MIM" ID="182601" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4925" />
                <XRef ID="4925" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 4 (SPG4; also known as SPAST-HSP) is characterized by insidiously progressive bilateral lower-limb gait spasticity. More than 50% of affected individuals have some weakness in the legs and impaired vibration sense at the ankles. Sphincter disturbances are very common. Onset is insidious, mostly in young adulthood, although symptoms may start as early as age one year and as late as age 76 years. Intrafamilial variation is considerable.</Attribute>
                <XRef ID="NBK1160" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301339</ID>
                <ID Source="BookShelf">NBK1160</ID>
              </Citation>
              <XRef ID="100985" DB="Orphanet" />
              <XRef ID="C1866855" DB="MedGen" />
              <XRef ID="MONDO:0008438" DB="MONDO" />
              <XRef Type="MIM" ID="182601" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357087" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="641883|MedGen:C1866855" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001195832" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24690193</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20562464</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17035675</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 1 through 4 of the SPAST gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 4 of the SPAST gene. Truncating variants in SPAST are known to be pathogenic (PMID: 20562464, 17035675). A similar deletion encompassing exons 1 through 4 of the SPAST gene has been reported to segregate with hereditary spastic paraplegia (HSP) in a single family. Of the five family members identified with the deletion, four displayed clinical symptoms of HSP (PMID: 24690193). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPAST" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_32288895)_(32323966_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Spastic paraplegia 4, autosomal dominant</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1866855" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357087" TraitType="Disease" MappingType="Name" MappingValue="Spastic paraplegia 4, autosomal dominant" MappingRef="Preferred">
        <MedGen CUI="C1866855" Name="Hereditary spastic paraplegia 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

